Remdesivir Bulk API Mixture from United States
Remdesivir bulk API mixture is an antiviral for the treatment of COVID-19 and Ebola, mixed for IV formulation production. Excluded from retail forms, it is classified under tariff item 3003.90.00 as a bulk antiviral medicament of mixed constituents.
Duty Rate — United States → Canada
0%
Import Tips
• Confirm the product is a mixture of two or more constituents, as pure remdesivir may be classified in Chapter 29
• Ensure the product is not in measured doses or retail packs
• Maintain documentation showing the intended use for further manufacturing